Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Mar 14, 2023 | Option Exercise | $5.51 | 8,351 | 45,990 | 114,637 | Mar 16, 2023, 04:49 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Mar 15, 2022 | Sale | $7.63 | 8,698 | 66,388 | 120,430 | Mar 17, 2022, 05:58 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Mar 15, 2021 | Sale | $38.14 | 6,164 | 235,089 | 102,574 | Mar 17, 2021, 05:00 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Oct 12, 2020 | Option Exercise | $22.13 | 48,466 | 1,072,795 | 132,603 | Oct 13, 2020, 04:34 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Oct 13, 2020 | Option Exercise | $22.13 | 22,062 | 488,342 | 119,401 | Oct 13, 2020, 04:34 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Oct 08, 2020 | Sale | $21.63 | 10,130 | 219,163 | 122,745 | Oct 09, 2020, 05:49 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Oct 09, 2020 | Sale | $24.22 | 69,708 | 1,688,421 | 147,879 | Oct 09, 2020, 05:49 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Oct 06, 2020 | Sale | $23.33 | 79,838 | 1,863,009 | 161,536 | Oct 08, 2020, 05:03 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Aug 13, 2020 | Option Exercise | $2.27 | 32,451 | 73,664 | 126,272 | Aug 14, 2020, 04:04 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Mar 16, 2020 | Sale | $19.19 | 3,750 | 71,980 | 63,021 | Mar 18, 2020, 04:32 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Sep 16, 2019 | Sale | $17.14 | 10,514 | 180,167 | 71,324 | Sep 18, 2019, 07:05 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Sep 17, 2019 | Sale | $17.19 | 45,006 | 773,642 | 88,570 | Sep 18, 2019, 07:05 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Sep 18, 2019 | Sale | $17.20 | 42,134 | 724,694 | 87,134 | Sep 18, 2019, 07:05 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Jul 30, 2019 | Sale | $16.06 | 23,638 | 379,567 | 77,192 | Jul 30, 2019, 06:23 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Jul 26, 2019 | Option Exercise | $15.73 | 26,386 | 414,942 | 78,566 | Jul 30, 2019, 06:23 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Jul 29, 2019 | Option Exercise | $15.83 | 47,630 | 753,931 | 89,188 | Jul 30, 2019, 06:23 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Jun 28, 2019 | Option Exercise | $2.27 | 27,816 | 63,142 | 65,373 | Jul 01, 2019, 04:32 PM | |
ALLO | Allogene Therapeutics, Inc. | MOORE ALISON | Chief Technical Officer | Jun 03, 2019 | Sale | $14.52 | 97,656 | 1,417,614 | 86,385 | Jun 05, 2019, 05:49 PM |